People were warned about DS a long time ago. Some good research was done into the companies benefiting from these dilutionary deals. One person's name kept coming up.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025